NEW YORK, Dec. 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
US Nucleic Acid Testing Market
http://www.reportlinker.com/p0591341/US-Nucleic-Acid-Testing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
Highlights
- Comprehensive 880-page market segmentation analysis of the US NAT market.
- Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
- Ten-year test volume and reagent sales forecasts for the following categories:
- Infectious Diseases
- Cancer
- Forensic Testing
- Genetic Diseases
- Paternity Testing/HLA Typing
- Review of testing methodologies and instrumentation technologies.
- Feature comparison of automated and semiautomated analyzers.
- Sales and market shares of leading suppliers.
- Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products.
- Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
Contains 880 pages and 37 tables
Table of Contents
Introduction
Worldwide Market And Technology Overview
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks
B. DNA And RNA Probe Technology
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
a. Sample Preparation
b. Hybridization
c. Separation
d. Detection/Measurement
4. Test Formats
a. Filter Hybridization
b. Southern Blot
c. Northern Blot
d. In Situ Hybridization
e. Others
5. Labeling Techniques
6. Amplification Methods Polymerase Chain Reaction
Temperature Cyclers
PCR Variations
ImmunoPCR
QCPCR
DAPPCR Strand Displacement Activation TMA Ligase Chain Reaction Branched DNA
Hybridization Protection Assay NucleicAcid SequenceBased Amplification SelfSustained Sequence Replicase Others
Ampliprobe
CAR
CAS
CPT
Dendritic Polymer Technology
ISOCR
LAT
Probe Networks
RAMP
Repair Chain Reaction
Rolling Circles
Sequence Independent Gene Amplification
Sequence Initiation Reaction
SISPA
C. Detection Technologies
1. Radioactive Methods
a. Overview
b. Major Isotopes P32 S35 H3 I125
2. NonIsotopic Methods
a. Enzymatic Labels
b. Chemical Labeling Indirect Chemical Labeling Direct Chemical Labeling
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity
D. Instrumentation Review
1. Abbott LCx
2. Autogenomics Infinity
3. Beckman Coulter/Biomek FK
4. Becton Dickinson SDA
5. BioRad GeneScope
6. GenProbe Tigris
7. Nanosphere Verigen Series
8. Roche Cobas Amplicor
9. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and
LabsontheChip
Liquid Transportation and Mixing
Separation
Reaction
Detection
F. Pharmacogenomics
G. Major Applications
1. Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
AIDS Structure and Composition Classification AIDS Origins Animal Lentivirus Systems Virus Receptors HIV Infections in Humans
Pathogenesis and Pathology CD4T Lymphocytes and Memory Cells Monocytes and Macrophages Lymphoid Organs Neural Cells Viral Coinfections
Clinical Findings Plasma Viral Load
Pediatric AIDS
Neurologic Disease
Opportunistic Infections
Cancer Immunity Laboratory Diagnosis
Virus Isolation
Serology
Viral Nucleic Acid/Antigen Detection Epidemiology
Worldwide Spread of AIDS
United States
Routes of Transmission Prevention, Treatment, And Control
Antiviral Drugs
Vaccines Transmission HIV in Blood Products HIV Transmission in Transplant
and Artificial Insemination Recipients Diagnostic Tests
Enzyme Immunoassay Interpretation
Specificity, Sensitivity and Predictive
Value Competition Assays Western Blot Technique ImmunoFluorescence Assays (IFA) Radioimmunoprecipitation HIV1/HIV2 Combination Testing Methods of HIVAntigen Detection Antigen Assays and Blood Screening Urine Tests DNA Probes
Overview
Quantitative PCR
In Situ PCR
Needed Improvements Viral Load/Drug Resistance Testing Genotype and Phenotype Testing Blood Banking Considerations
Adenovirus Background Diagnostic Tests Vaccines and Drugs AdenoAssociated Viruses (AAV)
Anthrax/Bacillus Anthracis Background Diagnostic Tests Vaccines and Drugs
Babesiosis Background
BEA and Other Bartonella Diseases Background Diagnostic Tests Vaccines and Drugs
Chagas Disease Background
Campylobacter Background Diagnostic Tests
Culture Identification Vaccines and Drugs
Chlamydia Background
Chlamydia psittaci
Chlmaydia pneumoniae
Chlamydia trachomatis Diagnostic Tests Vaccines and Drugs
CreutzfeldtJakob's Disease Background Blood Transmission Diagnostic Tests Major Commercial and Academic Players
Bayer
Disease Sciences/Bio Tec Global
Imperial College School of Medicine
OrthoClinical Diagnostics
Pall
ProMetic Life Sciences
Proteome Sciences/Idexx
QOne Biotech
Serono
U.S. Agricultural Research Service Drugs Vaccines
Cytomegalovirus Background
Chorioretinitis
Gastrointestinal
Central Nervous System Disease Diagnostic Tests Vaccines and Drugs
Ebola Virus Background
Epidemiology
Clinical Syndromes Diagnostic Tests Vaccines and Drugs
EchoVirus Background
Acute Aseptic Meningitisis
Encephalitis
Exanthems
Respiratory Disease
Myopericarditis
Neonatal Infections Diagnostic Tests Vaccines and Drugs
Encephalitis Background Diagnostic Tests Vaccines and Drugs
Enteroviruses Background Diagnostic Tests
Viral Isolation and Identification
Antibody Tests Vaccines and Drugs
EpsteinBarr Virus Background Diagnostic Tests Vaccines and Drugs
Gonorrhea Background Diagnostic Tests Vaccines and Drugs
Hepatitis Hepatitis A Hepatitis B
Structure and Composition
Replication Hepatitis C Hepatitis D (Delta) Hepatitis E Hepatitis G Hepatitis Infections Pathology Clinical Findings Laboratory Tests
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatitis E VirusHost Immune Reactions Epidemiology
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D (Delta) Vaccines and Drugs
Herpes Simplex Virus Background Diagnostic Tests Vaccines and Drugs
Legionella Background Diagnostic Tests Vaccines and Drugs
Lyme Disease Background
Clinical Description
Clinical Case Definition
Laboratory Criteria for Diagnosis
Case Classification Diagnostic Tests Vaccines and Drugs
Malaria
Mycoplasma Background
Ureaplasma Urealyticum & Mycoplasma
Hominis Diagnostic Tests Vaccines and Drugs
Papillomaviruses/HPV Background
HPV in Cancer
Cervical Neoplasm Diagnostic Tests Vaccines and Drugs Prevention
Parvovirus B19 Background
Microbiology
Epidemiology
Clinical Syndromes
Erythema Infectiosum (Slapped Cheek)
Adult Polyarthropathy
Transient Aplastic Crisis
Transient Pancytopenia
Red Cell Aplasia in Immunocompromised
Perinatal Infections Diagnostic Test Vaccines and Drugs
Pneumonia Background Diagnostic Tests Vaccines and Drugs
Polyomaviruses Background Diagnostic Tests Vaccines and Drugs
Salmonellosis Background Diagnostic Tests Vaccines and Drugs
Shigellosis Background Diagnostic Tests Vaccines and Drugs
Streptococci Background Diagnostic Tests Vaccines and Drugs
Group A Streptococci
Group B Streptococci
Toxoplasmosis Background Diagnostic Tests Vaccines and Drugs
Tuberculosis Background Diagnostic Tests
Microscopic Characteristics
Cultural Characteristics
Skin Tests
MDRTB Vaccines and Drugs
West Nile Virus Background
Clinical Syndromes Diagnostic Tests Vaccines and Drugs
Yersinia Background Diagnostic Tests Vaccines and Drugs
c. Antibiotic Susceptibility
2. Cancer Testing
a. Overview
b. Major Cancer Types
Prostate
Lung
Colon and Rectum
Breast
Skin
Uterine
Leukemia
Oral
c. Oncogenes Abl/ablbcr AIB1 BRCA1 CD44 Cfos Cmyb Cmyc CYP17 ErbB HPC1 Nmyc P40 P51 P53 PIK3CA PTI1 Ras Reg Sis Src
3. Genetic Diseases
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
Achondroplasia
Autosomal Dominant Polycystic Kidney
Disease
Cancer
Cosmetogenomics
Cystic Fibrosis
Down's Syndrome
Duchenne and Becker Muscular Dystrophy
Factor V (Leiden)
Factor IX Deficiency
Fragile X Syndrome
Heart Disease
Hemochomatosis
Hemophilia
Huntington's Disease
MaternalFetal Incompatibility
Multiple Endocrine Neoplasia
Phenylketonuria (PKU)
Polycystic Kidney Disease (PKD)
Prenatal Screening
Retinitis Pigmentosa
Retinoblastoma
Sickle Cell Anemia
Spinal Muscular Atrophy
Vitamin B12 Metabolism
i. Social Issues and Concerns
4. Forensic Testing
a. Overview
b. Multilocus and Single Locus Probes
Multilocus Probes
Single Locus Probes
PCR and RFLP
c. The FBI
d. DNA Profile Data Banks
U.S.A.
U.K.
e. Judicial Implementation
f. Major Crime Categories
g. Factors Contributing to the DNA Probe
Market Expansion
Technology Availability
Use of Hair as Evidence
h. Wildlife Forensics
5. Paternity Testing/HLA Typing
6. Other Applications
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Plasma Purification
f. Organ Transplantation
g. Water Contamination
h. Others
G. Cost Analysis
1. Equipment
2. Consumables
H. Competing/complementing Technologies
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two Dimensional Electrophoresis
4. Flow Cytometry
I. Reimbursement Issues
J. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
U.S.A.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
C. Market Structure
1. Hospitals
2. Commercial/Private Laboratories
3. Blood Banks
D. Market Size, Growth and Major Suppliers'
Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing
Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
Potential Market Entry Barriers And Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Profiles
Abbott
Aclara
Affymetrix
Agilent
Ambion
Applera
Applied Gene Technologies
Beckman Coulter
Becton Dickinson
Biokit
BioMerieux
Biotest
Boston Biomedica
Caliper
Cepheid
Chiron
Decode
Diadexus
Digene
Eiken
Enzo
Exact Sciences
Fujirebio
GenProbe
Gene Tec
Illumina
Innogenetics
Kreatech
LiCor
Molecular Diagnostics
Myriad Genetics
Nanogen
Nuvelo
Orchid Biosciences
Qiagen
Roche
Sangtec
Sequenom
Scienion
Sierra Diagnostics
Shimadzu
Takara Bio
Tepnel Life Sciences
Tecan Group
Third Wave
Appendixes
Appendix I: Major Companies Developing or Marketing
NAT Reagents and Test Kits
Appendix II: Major Universities and Research Centers
Developing NAT Technologies
Appendix III: Glossary of Terms
Appendix IV: Currency Exchange Rates
List of Tables
Major Companies Developing or Marketing Thermocyclers
Major Companies Developing or Marketing AIDS NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia NAT And Other Direct Identification Tests
Major Companies Developing or Marketing CMV NAT And Other Direct Identification Tests
Major Companies Developing or Marketing EBV NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma Virus NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis NAT And Other Direct Identification Tests
Major Companies Developing or Marketing Cancer NAT Tests
Major Companies Developing or Marketing NAT Assays For Genetic Diseases
Worldwide, Laboratories Performing DNA Sequencing By Country
Worldwide, NAT Market, Potential Laboratory Universe by Country
Worldwide, NAT Volume Forecast by Country
Worldwide, NAT Market Forecast by Country
Summary Table U.S.A., NAT Volume And Sales Forecast by Major Application
U.S.A., Laboratories Performing DNA Sequencing by Market Segment
U.S.A., NAT Market, Potential Laboratory Universe by Market Segment
U.S.A., NAT Volume Forecast By Major Application
U.S.A., Major Infectious Disease NAT Volume Forecast
U.S.A., Infectious Disease Screening NAT Volume by Test Forecast
U.S.A., NAT Market Forecast By Major Application
U.S.A., Infectious Disease Screening NAT Reagent Market Forecast by Test
U.S.A., NAT Market by Major Supplier
U.S.A., HIV/Hepatitis C NAT Market By Major Supplier
U.S.A., West Nile Virus NAT Market By Major Supplier
To order this report:
: US Nucleic Acid Testing Market
Check our Real Time Industry Data
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article